Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Mehrotra

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 18, 2008
A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimensYi Zhang, Nitin Mehrotra, Nageshwar R Budha, et al.
Biopharmaceutics & Drug Disposition|April 6, 2007
In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differencesNitin Mehrotra, Jawahar Lal, Sunil Kumar Puri, et al.
Clinical Pharmacology and Therapeutics|December 9, 2017
Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de PointesLars Johannesen, Christine Garnett, Man Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational AgentsMeredith K Chuk, Yeruk Mulugeta, Michelle Roth-Cline, et al.
Journal of Clinical Pharmacology|December 22, 2015
Utility of Exposure-Response Analysis in Regulatory Decision on the Selection of Starting Dose of Pasireotide for Cushing DiseaseJingyu Yu, Sang Chung, Immo Zadezensky, et al.
Biopharmaceutics & Drug Disposition|February 23, 2011
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shockPavan K Vaddady, Nitin Mehrotra, Xiaofeng Zhang, et al.
Journal of Clinical Pharmacology|January 23, 2015
Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimizationManoj Khurana, Jayabharathi Vaidyanathan, Anshu Marathe, et al.
Clinical Pharmacokinetics|December 13, 2025
Platform Assessment of Concentration-QTc Relationship Across GalNAc-siRNA MoleculesPrajakta Badri, Kiranmai Kolachana, Anh Duong, et al.
Vaccines|September 28, 2023
Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial VaccinesDaniel I S Rosenbloom, Julie Dudášová, Casey Davis, et al.
The AAPS Journal|May 1, 2008
Pharmacokinetically-guided lead optimization of nitrofuranylamide anti-tuberculosis agentsNageshwar R Budha, Nitin Mehrotra, Rajendra Tangallapally, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 18, 2008
A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimensYi Zhang, Nitin Mehrotra, Nageshwar R Budha, et al.
Biopharmaceutics & Drug Disposition|April 6, 2007
In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differencesNitin Mehrotra, Jawahar Lal, Sunil Kumar Puri, et al.
Clinical Pharmacology and Therapeutics|December 9, 2017
Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de PointesLars Johannesen, Christine Garnett, Man Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational AgentsMeredith K Chuk, Yeruk Mulugeta, Michelle Roth-Cline, et al.
Journal of Clinical Pharmacology|December 22, 2015
Utility of Exposure-Response Analysis in Regulatory Decision on the Selection of Starting Dose of Pasireotide for Cushing DiseaseJingyu Yu, Sang Chung, Immo Zadezensky, et al.
Biopharmaceutics & Drug Disposition|February 23, 2011
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shockPavan K Vaddady, Nitin Mehrotra, Xiaofeng Zhang, et al.
Journal of Clinical Pharmacology|January 23, 2015
Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimizationManoj Khurana, Jayabharathi Vaidyanathan, Anshu Marathe, et al.
Clinical Pharmacokinetics|December 13, 2025
Platform Assessment of Concentration-QTc Relationship Across GalNAc-siRNA MoleculesPrajakta Badri, Kiranmai Kolachana, Anh Duong, et al.
Vaccines|September 28, 2023
Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial VaccinesDaniel I S Rosenbloom, Julie Dudášová, Casey Davis, et al.
The AAPS Journal|May 1, 2008
Pharmacokinetically-guided lead optimization of nitrofuranylamide anti-tuberculosis agentsNageshwar R Budha, Nitin Mehrotra, Rajendra Tangallapally, et al.
Pageof 5